Transinsight Wins FutureSAX VC-Forum for Best Company

TransinsightFutureSAX invited venture capitalists and entrepreneurs from all over Germany to Dresden under the motto "Lift Off with Venture Capital - Emphasis on Technology and Environment." In front of 80 guests, among them 30 investors, the jury selected Transinsight with its software technology for knowledge-based information searches from seven finalists as the winner of the most promising investment.

"The jury choose the Transinsight team because of their excellent business concept and investment, as well as their convincing presentation", says futureSAX representative Kerstin Trautmann. She goes on to say: "the Businessplan-Wettbewerb Sachsen GmbH congratulates the winner for this outstanding success."

"We are proud our concept is regarded as outstanding by top-class investors", says Dr. Michael R. Alvers, CEO of Transinsight GmbH. He continues: "We created software with the potential to revolutionize information searching. Themed "Together we Search, Think, and Write", we raise searching to a new level. We do not rank search results, the user does! This fosters democracy and allows companies and others to save plenty of time, which then becomes available for other relevant tasks."

Mark Miller, CEO of CatCap and a member of the jury, is convinced that close cooperation between the university and new high-tech companies in Dresden will lead to success. "Transinsight GmbH, with its brand new search paradigm, is well-positioned in the rapidly growing information handling and knowledge management market," says Miller.

Related news articles:

About Transinsight
Founded in 2005, Transinsight is focused on software solutions for the life sciences providing products for knowledge-based technologies. The flagship product, www.gopubmed.com, a well established biomedical search engine, is the first knowledge-based search engine for the Life Sciences on the Internet. Transinsight is headquartered in one of the leading German biotech incubators, the BioInnovationCenter Dresden BIOZ, where science and business work under one roof. Transinsight works in close collaboration with the Technical University Dresden. For further information, visit www.transinsight.com.

About the VC Forum futureSAX
FutureSAX hosted a venture capital forum near the Frauenkirche for intensive discourse between venture capital investors. This forum has been the only VC networking forum to date in Saxony. Companies in the fields of technology and environment from all over Germany looking for investors could apply for one of eight presentation slots. FutureSAX was supported by KPMG and 3i Deutschland GmbH as well as by cooperation partners CatCap GmbH, Neuhaus Partners GmbH, and F.A.Z.-Institut GmbH. Investors were given the chance to get to know different outstanding companies during a single day as well as to get in contact with many potential co-investors. Companies were given the opportunity to present themselves in front of a community of investors. After the presentations, companies and investors got together over refreshments for one-on-one discussions. For further information, visit www.futuresax.de.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...